Artract is a developer of hemodynamic assist device intended for the treatment of the heart. The company's system is a passive hemodynamic assist device that is implanted percutaneously for the treatment of Heart Failure with preserved Ejection Fraction which reduces left atrial blood pressure, eases shortness of breath, increases heart chamber filling, Efficient treatment of heart failure, and no energy source or motor is required, thereby enabling users to improve their quality of life.

Investment: Pre-Seed, Series Seed (Lead)